These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 33904271

  • 21. Response to - a commentary on "Suppurative osteomyelitis, bisphosphonate induced 1 osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its 2 implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral. Maxillofac. Surg. 41 (3) (2012) 283-289].
    Marx RE, Tursun R.
    Int J Oral Maxillofac Surg; 2013 Jan; 42(1):148-9. PubMed ID: 23219001
    [No Abstract] [Full Text] [Related]

  • 22. Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis.
    Sarin J, DeRossi SS, Akintoye SO.
    Oral Dis; 2008 Apr; 14(3):277-85. PubMed ID: 18336375
    [Abstract] [Full Text] [Related]

  • 23. [Bisphosphonate-related osteonecrosis of the jaws].
    van der Waal I.
    Ned Tijdschr Tandheelkd; 2012 Apr; 119(4):206-11. PubMed ID: 22567818
    [Abstract] [Full Text] [Related]

  • 24. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V, American Association of Oral and Maxillofacial Surgeons, American Dental Association.
    Hawaii Dent J; 2008 Apr; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [Abstract] [Full Text] [Related]

  • 25. Bisphosphonate osteonecrosis of the jaw--a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention.
    Patel V, McLeod NM, Rogers SN, Brennan PA.
    Br J Oral Maxillofac Surg; 2011 Jun; 49(4):251-7. PubMed ID: 20605289
    [Abstract] [Full Text] [Related]

  • 26. [Bisphosphonate-associated osteonecrosis of the jaws. 3. Two case reports].
    Schortinghuis J, Meijndert L, de Visscher JG, Witjes MJ.
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):432-5. PubMed ID: 17972612
    [Abstract] [Full Text] [Related]

  • 27. Bisphosphonate-associated osteonecrosis of the jaw: a literature review and clinical practice guidelines.
    Pickett FA, American Academy of Oral Medicine.
    J Dent Hyg; 2006 Oct; 80(3):10. PubMed ID: 16953991
    [Abstract] [Full Text] [Related]

  • 28. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB.
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [Abstract] [Full Text] [Related]

  • 29. Bisphosphonates and osteonecrosis of the jaw: proceedings of an international conference.
    Bilezikian JP, Grbic JT.
    Ann N Y Acad Sci; 2011 Feb; 1218():1-2. PubMed ID: 21291476
    [Abstract] [Full Text] [Related]

  • 30. Bisphosphonate-related osteonecrosis of the jaws an old disease with a new drug?
    Carlson ER.
    Cranio; 2010 Jan; 28(1):1-2. PubMed ID: 20158003
    [No Abstract] [Full Text] [Related]

  • 31. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update.
    Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons.
    Aust Endod J; 2009 Dec; 35(3):119-30. PubMed ID: 19961450
    [No Abstract] [Full Text] [Related]

  • 32. Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review.
    Almazrooa SA, Woo SB.
    J Am Dent Assoc; 2009 Jul; 140(7):864-75. PubMed ID: 19571050
    [Abstract] [Full Text] [Related]

  • 33. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA, Liang STY, Sax AZ, Wu K, Yom SK, Huryn JM, Estilo CL.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [Abstract] [Full Text] [Related]

  • 34. Osteonecrosis of the jaw.
    Drozdzowska B.
    Endokrynol Pol; 2011 May; 62(1):88-92. PubMed ID: 21365586
    [Abstract] [Full Text] [Related]

  • 35. Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention.
    Gibbs SD, O'Grady J, Seymour JF, Prince HM.
    Med J Aust; 2005 Nov 21; 183(10):549-50. PubMed ID: 16296983
    [No Abstract] [Full Text] [Related]

  • 36. American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition.
    Colella G, Campisi G, Fusco V.
    J Oral Maxillofac Surg; 2009 Dec 21; 67(12):2698-9. PubMed ID: 19925998
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Osteonecrosis of the Jaw.
    Hamdy RC.
    J Clin Densitom; 2017 Dec 21; 20(1):1-2. PubMed ID: 28259260
    [No Abstract] [Full Text] [Related]

  • 39. Osteonecrosis of the Torus Palatinus in the Setting of Long-Term Oral Bisphosphonate Use--A Case Report.
    Ryan JL, Larson E.
    S D Med; 2016 Jan 21; 69(1):23-5. PubMed ID: 26882578
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.